Advanced search
Publication Cover
Psoriasis: Targets and Therapy Volume 6, 2016 - Issue
Submit an article Journal homepage
265
Views
16
CrossRef citations to date
0
Altmetric
Review

Psoriasis and inflammatory bowel disease: links and risks

Christoforos Vlachos1 Department of Skin and Venereal Diseases
,
Georgios Gaitanis1 Department of Skin and Venereal Diseases
,
Konstantinos H Katsanos2 Division of Gastroenterology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece
,
Dimitrios K Christodoulou2 Division of Gastroenterology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece
,
Epameinondas Tsianos2 Division of Gastroenterology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece
&
Ioannis D Bassukas1 Department of Skin and Venereal DiseasesCorrespondence[email protected]
Pages 73-92 | Published online: 20 Jul 2016

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Claudio Conforti, Caterina Dianzani, Iris Zalaudek, Michele Cicala, Paolo Persichetti, Roberta Giuffrida, Silviu-Horia Morariu & Nicoleta Neagu. (2022) Spotlight on the treatment armamentarium of concomitant psoriasis and inflammatory bowel disease: a systematic review. Journal of Dermatological Treatment 33:3, pages 1279-1286.
Read now
Carlo Alberto Maronese, Enrico Zelin, Chiara Moltrasio, Giovanni Genovese & Angelo Valerio Marzano. (2021) Genetic screening in new onset inflammatory bowel disease during anti-interleukin 17 therapy: unmet needs and call for action. Expert Opinion on Biological Therapy 21:12, pages 1543-1546.
Read now

Articles from other publishers (14)

Zuzana Reiss, Filip Rob, Martin Kolar, Dagmar Schierova, Jakub Kreisinger, Zuzana Jackova, Radka Roubalova, Stepan Coufal, Martin Mihula, Tomas Thon, Lukas Bajer, Michaela Novakova, Martin Vasatko, Klara Kostovcikova, Natalie Galanova, Milan Lukas, Miloslav Kverka, Jana Tresnak Hercogova, Helena Tlaskalova-Hogenova & Zuzana Jiraskova Zakostelska. (2023) Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Alina Mihaela Morosanu, Ioana Ruxandra Mihai & Ioana Irina Rezus. (2022) New onset severe ulcerative colitis following Ixekizumab therapy. Archive of Clinical Cases 9:4, pages 173-176.
Crossref
Klas Agerberg & Anders Rönnblom. (2022) Debut of Psoriasis is usually before Debut of Concomitant Inflammatory Bowel Disease: A Population-based Retrospective Study. Acta Dermato-Venereologica 102, pages adv00714.
Crossref
Laura Țiburcă, Marius Bembea, Dana Carmen Zaha, Alexandru Daniel Jurca, Cosmin Mihai Vesa, Ioana Adela Rațiu & Claudia Maria Jurca. (2022) The Treatment with Interleukin 17 Inhibitors and Immune-Mediated Inflammatory Diseases. Current Issues in Molecular Biology 44:5, pages 1851-1866.
Crossref
Maria Antonia De Francesco & Arnaldo Caruso. (2022) The Gut Microbiome in Psoriasis and Crohn’s Disease: Is Its Perturbation a Common Denominator for Their Pathogenesis?. Vaccines 10:2, pages 244.
Crossref
Chaonan Sun, Ling Chen, Huan Yang, Hongjiang Sun, Zhen Xie, Bei Zhao, Xuemei Jiang, Bi Qin & Zhu Shen. (2021) Involvement of Gut Microbiota in the Development of Psoriasis Vulgaris. Frontiers in Nutrition 8.
Crossref
Xiaoqian Liang, Caixin Ou, Jiayi Zhuang, Jinsheng Li, Fangfei Zhang, Yuanqiu Zhong & Yongfeng Chen. (2021) Interplay Between Skin Microbiota Dysbiosis and the Host Immune System in Psoriasis: Potential Pathogenesis. Frontiers in Immunology 12.
Crossref
Mi Ran Kim & Hyung Seo Hwang. (2021) Brazilin downregulates CCL20 expression via regulation of STAT3 phosphorylation in TNF-α/IL-17A/IFN-γ-induced HaCaT cells. Journal of Applied Biological Chemistry 64:2, pages 185-192.
Crossref
Ehizogie Edigin, Jennifer Asotibe, Precious Obehi Eseaton, Olukayode Ahmed Busari, Ikechukwu Achebe, Asim Kichloo, Shakeel Jamal & Axi Patel. (2023) Coexisting Psoriasis is Associated with An Increased Risk of Hospitalization for Patients with Inflammatory Bowel Disease: An Analysis of the National Inpatient Sample Database. Journal of Investigative Medicine 69:4, pages 857-862.
Crossref
Yi-Teng Hung, Puo-Hsien Le, Chia-Jung Kuo, Yu-Chuan Tang, Meng-Jiun Chiou, Cheng-Tang Chiu, Chang-Fu Kuo & Yu-Huei Huang. (2021) The Temporal Relationships and Associations between Cutaneous Manifestations and Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study. Journal of Clinical Medicine 10:6, pages 1311.
Crossref
Yan Jiang, Karolin Jarr, Cosima Layton, Christopher D. Gardner, Judith F. Ashouri, Maria T. Abreu & Sidhartha R. Sinha. (2021) Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases. Nutrients 13:3, pages 890.
Crossref
Anthony Passarella, Prabhsharn Grewal & Raluca Vrabie. 2021. Inflammatory Bowel Disease. Inflammatory Bowel Disease 25 59 .
Aristo Vojdani, Elroy Vojdani, Martha Herbert & Datis Kharrazian. (2020) Correlation between Antibodies to Bacterial Lipopolysaccharides and Barrier Proteins in Sera Positive for ASCA and ANCA. International Journal of Molecular Sciences 21:4, pages 1381.
Crossref
Paul Scutt. (2019) Emerging Insights in the Treatment of Psoriasis and Psoriatic Arthritis. EMJ Dermatology, pages 79-87.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.